Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-05-15 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −9,847 204,100
2018-05-14 HAYDEN DONALD J JR Director Exercise or conversion +5,153 $0.85 $4K 5,153
2018-05-14 HAYDEN DONALD J JR Director Sale −5,153 $50.04 $258K 0
2018-05-14 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −5,153 213,947
2018-05-10 Christmas Patrick J. SVP, General Counsel Exercise or conversion +15,000 $12.10 $182K 16,141
2018-05-10 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 75,000
2018-05-09 Christmas Patrick J. SVP, General Counsel Exercise or conversion +15,000 $12.10 $182K 16,141
2018-05-09 Christmas Patrick J. SVP, General Counsel Sale −5,000 $42.00 $210K 11,141
2018-05-09 Christmas Patrick J. SVP, General Counsel Sale −10,000 $44.00 $440K 1,141
2018-05-09 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 90,000
2018-05-09 HAYDEN DONALD J JR Director Exercise or conversion +15,000 $0.85 $13K 15,000
2018-05-09 HAYDEN DONALD J JR Director Sale −15,000 $45.00 $675K 0
2018-05-09 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −15,000 219,100
2018-04-20 Mills Kenneth T. President and CEO Sale −9,100 $39.48 $359K 219,430
2018-04-20 Mills Kenneth T. President and CEO Sale −900 $39.93 $36K 218,530
2018-04-16 Vasista Vittal Chief Financial Officer Sale −2,849 $37.34 $106K 154,434
2018-04-16 Vasista Vittal Chief Financial Officer Sale −2,151 $37.85 $81K 152,283
2018-04-11 Christmas Patrick J. SVP, General Counsel Exercise or conversion +10,000 $12.10 $121K 11,141
2018-04-11 Christmas Patrick J. SVP, General Counsel Sale −10,000 $39.00 $390K 1,141
2018-04-11 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −10,000 105,000

Page 42 of 43 · 852 trades